Concept: California’s healthtech startup AliveCor has launched the world’s first credit card-sized slim personal electrocardiogram (ECG) device named KardiaMobile Card for instant feedback on heart health. The startup claims that the device can easily fit into any wallet and offers a medical-grade, single-lead ECG in 30 seconds.
Nature of Disruption: KardiaMobile Card pairs with a smartphone leveraging Bluetooth technology to detect six of the most common arrhythmias including AFib, Bradycardia, Tachycardia, PVCs, Sinus Rhythm with SVE, and Sinus Rhythm. It provides users with access to cardiologist analyses of ECGs, monthly heart health reports, and automatic sharing of ECG recordings. The personal ECG device’s algorithm is based on AliveCor’s AI-enabled Kardia technology that has been evaluated by more than 170 peer-reviewed studies. The startup claims that KardiaMobile Card is designed to resist weather, water, and wear and tear. The device offers a 30-second to five minutes recording duration and has 300 samples per second sampling rate. The device has a non-replaceable battery that offers a usage time of up to two years. The device comes with one-year access to KardiaCare, a heart health service that offers the users a suite of advanced features to help them better manage and understand their heart health.
Go deeper with GlobalData
Outlook: According to the World Health Organization (WHO), cardiovascular disease (CVDs) are one of the leading causes of death globally. In 2019, an estimated 17.9 million people died from CVDs which represents about one in three deaths globally. The majority of CVD deaths take place in low- and middle-income countries. AliveCor claims that the KardiaMobile Card is a slim and convenient personal ECG device that delivers a medical-grade, single-lead ECG in 30 seconds. It enables the users to get instant feedback on heart health anytime, anywhere. In February 2022, AliveCor announced that KardiaMobile Card received clearance from the US Food and Drug Administration (FDA) for sale in the US.
This article was originally published in Verdict.co.uk
